D-1388-2020 Class III Terminated
FDA drug recall D-1388-2020 was initiated by Akorn, Inc. on Dec 26, 2019 and is designated Class III. Reason for recall: Chemical contamination; out of specification results obtained for equipment cleaning residue rinse sample The recall status is terminated (terminated Jul 28, 2022). Affected quantity: 33,343 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 22, 2020
- Initiation Date
- Dec 26, 2019
- Termination Date
- Jul 28, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 33,343 bottles
Product description
Proparacaine Hydrochloride Ophthalmic Solution, USP, 0.5%, 15 mL per dropper bottle, Sterile, Rx Only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. NDC 17478-263-12
Reason for recall
Chemical contamination; out of specification results obtained for equipment cleaning residue rinse sample
Distribution pattern
Nationwide USA and Puerto Rico
Code information
Lot 9E52A, exp 04/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1388-2020
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026